Umberto Pensato on Reperfusion Outcomes in Stroke
Umberto Pensato, Assistant Professor of Neurology at the Humanitas University, Research Collaborator at the University of Calgary, shared on LinkedIn:
”In this opinion paper published in Stroke, we argue against reperfusion in every ischemic stroke patient.
Reperfusion can be beneficial, futile, or harmful depending on the extension and (most importantly) severity of the ischemic core.
Moreover, both relative and absolute treatment effects should be considered for treatment decision-making.
Notably, this opinion paper was born from a vivid discussion about a single patient with my Canadian mentors: Michael Hill, Bijoy Menon, Johanna Ospel, Andrew Demchuk; Humanitas University; University of Calgary; American Heart Association”
Read the full article in Stroke.
Article: Futile and Harmful Reperfusion and the Balance Between Treatment Effect and Overall Outcomes in Stroke
Authors: Umberto Pensato, Michael D. Hill, Bijoy K. Menon, Andrew M. Demchuk, Johanna M. Ospel
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks